M&A activity to fuel growth for India's pharma sector
Kaustubh Chaubal, a Moody's Vice President and Senior Analyst said, "The drive for overseas expansion comes amid the consolidation of the global pharmaceutical industry, as drug companies look to boost their product and pipeline diversity, scale and pricing power."

Strong financial portfolios of the Indian pharma companies are well capable of large acquisitions, which will in turn tap its growth further. Photo: Pixabay